Skip to content

Clinical trials

Phase 2 Alzheimer Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Country / region: United States Clear all

358 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20036
20048
200510
200616
200713
200817
200922
20107
201119
201217
20134
201410
201513
201612
201716
201823
201916
202015
202121
202218
202313
202417
202516
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed220
Terminated50
Recruiting38
Active, not recruiting17
Unknown status15
Withdrawn7
Enrolling by invitation6
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company12
Pfizer11
Avid Radiopharmaceuticals9
University of Wisconsin, Madison6
AbbVie (prior sponsor, Abbott)5
Columbia University5
Genentech, Inc.5
GlaxoSmithKline5
JANSSEN Alzheimer Immunotherapy Research & Development, LLC5
National Institute on Aging (NIA)5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease358
Cognitive Dysfunction90
Dementia71
Memory Disorders16
Neurodegenerative Diseases15
Brain Diseases14
Central Nervous System Diseases14
Psychomotor Agitation14
Inflammation9
Nervous System Diseases9

Trials

Showing 1 to 25 of 358. Each trial links to its page on Pharma Observatory.

258 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.